Jacob Laubach, MD, MPP

Dr. Laubach is Clinical Director and Senior of the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School.

Articles by Jacob Laubach, MD, MPP

Are Four-Drug Combinations the Future for Newly Diagnosed Myeloma?

Jacob Laubach, MD, MPPMyeloma | November 14, 2022

Jacob Laubach, MD, MPP, from Dana-Farber Cancer Institute, shares his thoughts.

Jacob Laubach on Long-Term Results With Daratumumab Plus RVd

Jacob Laubach, MD, MPPMyeloma | November 14, 2022

Dr. Laubach, from Dana-Farber Cancer Institute, reviews follow-up data from the phase II GRIFFIN trial.